Mirae Asset Global Investments Co., Ltd. Revolution Medicines, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $37.3 Billion
- Q1 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 6,221 shares of RVMD stock, worth $252,448. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,221
Previous 5,606
10.97%
Holding current value
$252,448
Previous $245,000
10.61%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding RVMD
# of Institutions
303Shares Held
189MCall Options Held
186KPut Options Held
672K-
Vanguard Group Inc Valley Forge, PA16.6MShares$674 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.5MShares$549 Million2.75% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$544 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$478 Million0.08% of portfolio
-
Janus Henderson Group PLC London, X010.2MShares$414 Million0.21% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.56B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...